AEM
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AEM Accepts, published online ahead of print on 26 November 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AEM.02106-07v1
74/2/446    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuroda, K.
Right arrow Articles by Jigami, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuroda, K.
Right arrow Articles by Jigami, Y.
Agricola
Right arrow Articles by Kuroda, K.
Right arrow Articles by Jigami, Y.

 Previous Article  |  Next Article 

Appl. Environ. Microbiol. doi:10.1128/AEM.02106-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Efficient antibody production with the suppression of O-mannosylation in yeast

Kousuke Kuroda, Kazuo Kobayashi, Yoshinori Kitagawa, Taishiro Nakagawa, Haruhiko Tsumura, Toshihiro Komeda, Daisuke Shinmi, Eiji Mori, Kazuhiro Motoki, Kazumi Hujiu, Teruyuki Sakai, Koichi Nonaka, Takeshi Suzuki, Kimihisa Ichikawa, Yasunori Chiba, and Yoshifumi Jigami*

Kirin Pharma Co., Ltd., CMC R&D Laboratories, Gunma, Japan; Kirin Pharma Co., Ltd., Production Planning, Tokyo, Japan; Kirin Holdings Co., Ltd., Central Laboratories for Frontier Technology, Gunma, Japan; Kirin Pharma Co., Ltd., Discovery Research Laboratories, Gunma, Japan; Daiichi Sankyo Co., Ltd., Process Technology Research Laboratories, Fukushima, Japan; Daiichi Sankyo Co., Ltd., Advanced Technology Research Laboratories, Tokyo, Japan; National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, Japan; Graduate School of Life and Environmental Science, University of Tsukuba, Ibaraki, Japan

* To whom correspondence should be addressed. Email: jigami.yoshi{at}aist.go.jp.


   Abstract

When antibodies were expressed in a methylotrophic yeast Ogataea minuta, we found that abnormal O-mannosylation occurred in the secreted antibody. Yeast-specific O-mannosylation is initiated by the addition of mannose at serine (Ser) or threonine (Thr) residues in the endoplasmic reticulum (ER) via protein O-mannosyltransferase (Pmt) activity. To suppress the addition of O-linked sugar chains on antibodies, we examined the possibility of inhibiting Pmt activity by the addition of a Pmt inhibitor during cultivation. The Pmt inhibitor was found to partially suppress the O-mannosylation on the antibodies. Surprisingly, the suppression of O-mannosylation was associated with an increased amount of assembled antibody (H2L2) and enhanced the antigen-binding activity of the secreted antibody. In this study, we demonstrated the expression of human antibody in O. minuta and elucidated the relationship between O-mannosylation and antibody production in yeast.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Microbiol. Mol. Biol. Rev. Eukaryot. Cell All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.